These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 18056788)

  • 1. Intraportally delivered GLP-1, in the presence of hyperglycemia induced via peripheral glucose infusion, does not change whole body glucose utilization.
    Johnson KM; Edgerton DS; Rodewald T; Scott M; Farmer B; Neal D; Cherrington AD
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E380-4. PubMed ID: 18056788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels.
    Johnson KM; Edgerton DS; Rodewald T; Scott M; Farmer B; Neal D; Cherrington AD
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1085-91. PubMed ID: 17684104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intraportal glucagon-like peptide-1 on glucose metabolism in conscious dogs.
    Nishizawa M; Moore MC; Shiota M; Gustavson SM; Snead WL; Neal DW; Cherrington AD
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E1027-36. PubMed ID: 12569088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the hepatic sympathetic nerves in the regulation of net hepatic glucose uptake and the mediation of the portal glucose signal.
    Dicostanzo CA; Dardevet DP; Neal DW; Lautz M; Allen E; Snead W; Cherrington AD
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E9-E16. PubMed ID: 16105863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of dipeptidyl peptidase-4 by vildagliptin during glucagon-like Peptide 1 infusion increases liver glucose uptake in the conscious dog.
    Edgerton DS; Johnson KM; Neal DW; Scott M; Hobbs CH; Zhang X; Duttaroy A; Cherrington AD
    Diabetes; 2009 Jan; 58(1):243-9. PubMed ID: 18840785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the nitric oxide donor SIN-1 on net hepatic glucose uptake in the conscious dog.
    An Z; DiCostanzo CA; Moore MC; Edgerton DS; Dardevet DP; Neal DW; Cherrington AD
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E300-6. PubMed ID: 18029444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide 1.
    Nauck MA; Walberg J; Vethacke A; El-Ouaghlidi A; Senkal M; Holst JJ; Gallwitz B; Schmidt WE; Schmiegel W
    Regul Pept; 2004 Apr; 118(1-2):89-97. PubMed ID: 14759561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatic artery ligation does not prevent liver from differentiating portal vs. peripheral glucose delivery.
    Moore MC; Burish MJ; Farmer B; Neal DW; Pan C; Cherrington AD
    Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E845-53. PubMed ID: 12773306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans.
    Vella A; Shah P; Reed AS; Adkins AS; Basu R; Rizza RA
    Diabetologia; 2002 Oct; 45(10):1410-5. PubMed ID: 12378382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenously imposed postprandial-like rises in systemic glucose and GLP-1 do not produce an incretin effect, suggesting an indirect mechanism of GLP-1 action.
    Ionut V; Liberty IF; Hucking K; Lottati M; Stefanovski D; Zheng D; Bergman RN
    Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E779-85. PubMed ID: 16720628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A negative arterial-portal venous glucose gradient decreases skeletal muscle glucose uptake.
    Galassetti P; Shiota M; Zinker BA; Wasserman DH; Cherrington AD
    Am J Physiol; 1998 Jul; 275(1):E101-11. PubMed ID: 9688880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of net hepatic substrate balance by phenacylimidazolium ions in the conscious dog.
    Pagliassotti MJ; Colburn CA; Moore MC; Neal DW; Dominianni SJ; Stephens TW; Cherrington AD
    Diabetes Res; 1993; 22(3):123-33. PubMed ID: 7915646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output.
    Everett-Grueter C; Edgerton DS; Donahue EP; Vaughan S; Chu CA; Sindelar DK; Cherrington AD
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E449-59. PubMed ID: 16608886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraportal GLP-1 stimulates insulin secretion predominantly through the hepatoportal-pancreatic vagal reflex pathways.
    Nishizawa M; Nakabayashi H; Uehara K; Nakagawa A; Uchida K; Koya D
    Am J Physiol Endocrinol Metab; 2013 Aug; 305(3):E376-87. PubMed ID: 23715725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-independent effects of GLP-1 on canine liver glucose metabolism: duration of infusion and involvement of hepatoportal region.
    Dardevet D; Moore MC; Neal D; DiCostanzo CA; Snead W; Cherrington AD
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E75-81. PubMed ID: 15026303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unlike mice, dogs exhibit effective glucoregulation during low-dose portal and peripheral glucose infusion.
    Moore MC; Cardin S; Edgerton DS; Farmer B; Neal DW; Lautz M; Cherrington AD
    Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E226-33. PubMed ID: 14519598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of continuous and pulsatile insulin delivery on net hepatic glucose uptake.
    Grubert JM; Lautz M; Lacy DB; Moore MC; Farmer B; Penaloza A; Cherrington AD; McGuinness OP
    Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E232-40. PubMed ID: 15755768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the portal signal in a nonsteady hyperglycemic state in conscious dogs.
    Ogihara N; Ebihara S; Kawamura W; Okamoto M; Sakai T; Takiguchi K; Morita T; Uchida R; Matsuyama Y; Hayashi Y; Arakawa Y; Kikuchi M
    Am J Physiol Endocrinol Metab; 2003 Jan; 284(1):E148-55. PubMed ID: 12388150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FK-614, a selective peroxisome proliferator-activated receptor gamma agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs.
    Uchino H; Kim T; Lam TK; Yoshii H; Klement P; Williams W; Kawamori R; Giacca A
    Metabolism; 2005 Sep; 54(9):1250-8. PubMed ID: 16125538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inclusion of low amounts of fructose with an intraportal glucose load increases net hepatic glucose uptake in the presence of relative insulin deficiency in dog.
    Shiota M; Galassetti P; Igawa K; Neal DW; Cherrington AD
    Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1160-7. PubMed ID: 15671083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.